San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1

Regulations
May.18.2022
San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1
San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1

The San Diego City Council officially passed an ordinance Tuesday to ban the sale of flavored tobacco products — including menthol — in the city, effective Jan. 1, 2023.

 

The move — spearheaded by Councilwoman Marni von Wilpert — follows similar actions in cities such as Imperial Beach, Encinitas and Solana Beach, along with San Diego County for unincorporated areas. It also comes months before a statewide referendum tackling the issue in November.

 

The council passed the first reading of the issue in April. This second vote makes the ordinance — known as the Stop Adolescent Addiction From E-Cigarettes or SAAFE Act — law.

 

“I thank my colleagues for standing with me to stop Big Tobacco from addicting an entire new generation of youth on tobacco products by officially approving the SAAFE Act,” von Wilpert said. 

 

“Flavored tobacco products are intentionally marketed to kids and I am proud that our city is taking action to prevent the sale of these products and protect our youth.”

 

The ordinance does not apply to the sale of shisha, premium cigars or loose-leaf tobacco and unflavored or tobacco-flavored e-cigarettes, as well as FDA-approved cessation devices that will also be exempt from the ban.

 

Councilwoman Jennifer Campbell said in her 40 years practicing medicine, she had seen the impact on children who lived in homes with smokers.

 

“We must stop Big Tobacco from aggressively targeting our children and vulnerable communities,” she said. “The Stop Adolescent Addiction From E-Cigarettes will help protect our communities from the tobacco industry making life-long customers addicted to nicotine.”

 

According to findings presented in April by von Wilpert’s office, in the most recent completed study of the city’s tobacco retailers in 2019, 14.7% of retailers sold to an underage police decoy. In a study to come, she said, those numbers have increased to nearly 30%.

 

Source:TIMESOFSANDIEGO

In opposition to the law at the lengthy public hearing in April were dozens of small business owners, who claimed flavored tobacco made up anywhere from 25% to nearly half of their business. Nearly all of them claimed they were law-abiding business owners who had been commended by the San Diego Police Department for their above-board operations. Several also decried what they called the paternalistic nature of the city council’s new law, saying parents should be in charge of how children were raised, not the government.

Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28